Genzyme's new offer for AnorMed tops Millennium's
Globe and Mail
October 11, 2006

Xenon deal seen as bolstering B.C.’s global biotech reputation
Business in Vancouver
October 10-16, 2006


Xenon signs with Japanese company
Vancouver Sun
October 3, 2006


Japan’s drug firms branching out
Vancouver Sun
October 3, 2006


Buyout Bid Boosts Anormed Shares
Vancouver Sun
September 27, 2006


Millennium Pharma to buy AnorMed
Globe and Mail
September 26, 2006


Victoria biotech company values its employees above all
Vancouver Sun
September 25, 2006


Angiotech battered by Boston Scientific warning
Globe and Mail
September 22, 2006


Burnaby biotech works on cure for deadly poison
NewsLeader
September 22, 2006


Inex shareholders OK spinout
Globe and Mail
September 21, 2006


Life sciences standouts
Globe and Mail
September 21, 2006


Investment yields 272% return
Vancouver Sun
September 21, 2006


Biotech industry loses risk aversion
Vancouver Sun
September 21, 2006


Stay tuned, AnorMed chief tells shareholders
Vancouver Sun
September 20, 2006


Burnaby biotech on trail of terrorism tool
Business in Vancouver
September 19-25, 2006


Anormed hits milestone
Globe and Mail
September 18, 2006


Scientists devise world’s first genetic ‘blueprint’ for trees
Vancouver Sun
September 15, 2006


Cardiome drug tests fail to please
Globe and Mail
September 14, 2006


AnorMed stock doubles after it says no to Genzyme’s offer
Vancouver Sun
August 31, 2006


QLT shares perk up after news of bid to buy company
Vancouver Sun
August 30, 2006